A systematic review and meta-analysis of the etiology and treatment patterns of thyrotoxicosis in Africa

References

• Fröhlich E, Wahl R. Physiological role and use of thyroid hormone metabolites - potential utility in COVID-19 patients. Front Endocrinol (Lausanne). 2021;12:[cited 2022 Apr 21]:Internet https://www.frontiersin.org/article/10.3389/fendo.2021.587518
   PubMed Web of Science ®Google Scholar
• Ale AO, Odusan O. Spectrum of endocrine disorders as seen in a tertiary health facility in Sagamu, Southwest Nigeria. Niger Med J. 2019 Sep 1;60(5):252.
   PubMedGoogle Scholar
• Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011 Sep 1;99(1):39–51.
   PubMed Web of Science ®Google Scholar
• Crafa A, Calogero AE, Cannarella R, et al. The burden of hormonal disorders: a worldwide overview with a particular look in Italy. Front Endocrinol (Lausanne). 2021; [cited 2022 Apr 21] 12 Internet https://www.frontiersin.org/article/10.3389/fendo.2021.694325
   Web of Science ®Google Scholar
• Balde NM, Balde MD, Kake A, et al. Hyperthyroidism in conakry: clinical and therapeutic features. Annales de l’Université Marien NGOUABI. 2007;8:23–27.
   Google Scholar
• Nouh AB, Ehnaf I, Basher M. Prevalence of thyroid dysfunction and its effect on serum lipid profiles in a Murzok, Libya population. Thyroid Sci. 2008;3(10):1–6.
   Google Scholar
• Saeed AK, Ahmed K, Elmahdi E, et al. The prevalence of thyroid dysfunction among Sudanese pregnant women. Sojgow. 2015;1(1):1–5.
   Google Scholar
• Awede B, Hounnou MS, Tshabu-Aguemon C, et al. Thyroid function in pregnant women from a West-African population. Open J Mol Integr Physiol. [2018 Feb 9];8(1):1–11.
   Google Scholar
• Okafor EN, Ugonabo MC, Chukwukelu EE, et al. Prevalence and pattern of thyroid disorders among patients attending university of Nigeria teaching hospital, Enugu, Southeastern Nigeria. Niger Med J. 2019;60(2):62–67.
   PubMedGoogle Scholar
• Keunmoe P, Halle MP, Assob Nguedia JC, et al. The spectrum of Thyroid function Abnormalities and associated biochemical factors in patients with chronic kidney disease in Cameroon. American Journal of Biomedical Science & Research. 2020;8(5):387–396.
   Google Scholar
• Meng Z, Liu M, Zhang Q, et al. Gender and age impacts on the association between thyroid function and metabolic syndrome in Chinese. Medicine (Baltimore). 2015 Dec 18 94(50):e2193.
   PubMed Web of Science ®Google Scholar
• Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American thyroid association and American association of clinical endocrinologists. Thyroid. 2011 Jun;21(6):593–646.
   PubMed Web of Science ®Google Scholar
• De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016 Aug 27;388(10047):906–918.
   PubMed Web of Science ®Google Scholar
• Ma LL, Wang YY, Yang ZH, et al. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020 Feb 29;7(1):7.
   PubMed Web of Science ®Google Scholar
• Melsen WG, Bootsma MCJ, Rovers MM, et al. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect. 2014 Feb 1;20(2):123–129.
   PubMed Web of Science ®Google Scholar
• Steele J, Plotkin D, Van Every D, et al. Slow and steady, or hard and fast? A systematic review and meta-analysis of studies comparing body composition changes between interval training and moderate intensity continuous training. Sports. 2021 Nov;9(11):155.
   Google Scholar
• Abdulkadir J, Besrat A, Abraham G, et al. Thyrotoxicosis in Ethiopian patients–a prospective study. Trans R Soc Trop Med Hyg. 1982;76(4):500–502.
   PubMed Web of Science ®Google Scholar
• Mengistu M. The pattern of thyroid diseases in adult Ethiopians and experience in management. Ethiop Med J. 1993 Jan 1;31(1):25–36.
   PubMedGoogle Scholar
• Akossou SY, Napporn A, Goeh-Akue E, et al. Problems in the management of thyrotoxicosis in Black Africa: the Tongolese experience. Ann Endocrinol (Paris). 2001 Dec;62(6):516–520.
   PubMed Web of Science ®Google Scholar
• Mohammed K. Graves’Disease frequency and clinical patterns in Khartoum teaching hospital January - July 2004. Sudan: University of Khartoum; 2004.
   Google Scholar
• Sigilai K. Presentation and surgical management of hyperthyroidism in Kenyatta national hospital [master of medicine]. Kenya: University of Nairobi; 2003.
   Google Scholar
• Ogbera AO, Fasanmade O, Isiba A. The scope o f cardiac complications of thyrotoxicosis in Lagos, Nigeria. Pak J Med Sci Q. 2007;23(5):671–675.
   Web of Science ®Google Scholar
• Ogbera AO, Fasanmade O, Adediran O. Pattern of thyroid disorders in the southwestern region of Nigeria. Ethn Dis. 2007;17(2):327–330.
   PubMed Web of Science ®Google Scholar
• Sidibé AT, Dembélé M, Diarra AS, et al. Hyperthyroïdie chez l’enfant. Experience d’un service de médecine interne au Mali. Ann Endocrinol. [2007 Jun 1];68(2):177–180.
   PubMedGoogle Scholar
• El Hattaoui M, Charei N, Mouniri M, et al. Cardiothyréoses dans la région de Marrakech. À propos de 36 cas. Annales de Cardiologie et d’Angéiologie. 2009 Jun 1;58(3):135–138.
   PubMedGoogle Scholar
• Ali N, Madziga AG, Dogo D, et al. Outcome of surgery for toxic goitres in Maiduguri: a single teaching hospital’s perspective. Niger J Clin Pract. 2012 Jul 1;15(3):280.
   PubMed Web of Science ®Google Scholar
• Kebede D, Abay Z, Feleke Y. Pattern, clinical presentations and management of thyroid diseases in national endocrine referral clinics, Tikur Anbessa specialized Hospital, Addis Ababa, Ethiopia. Ethiop Med J. 2012 Oct;50(4):287–295.
   PubMedGoogle Scholar
• Onyenekwe BM. Thyrotoxicosis, etiology, presentation and management challenges in Nigeria: a review of cases seen over a 5 year period. Eur Sci J. 2019 Aug 31;15(24):144–144.
   Google Scholar
• Dionadji M, Abbas O, Mbero M. Caractéristiques Cliniques et Biologiques de l’Hyperthyroïdie à N’Djamena. Health Sci Dis Internet]. 2015 Dec 8 [cited 2022 Apr 1];16(4). Available from . [];(). http://www.hsd-fmsb.org/index.php/hsd/article/view/590
   Google Scholar
• Ekpebegh C, Longo-Mbenza B, BlancoBlanco E. Autoimmune clinical features and thyroid antibody profiles in Black South Africans with toxic Graves and primary Hypothyroidsim. Int J Endocrinol Metab Disord. 2015;1(4):1–5.
   Google Scholar
• Balde NM, Balde MD, Kake A, et al. Hyperthyroidie au cours de la pathologie thyroidienne: frequence, particularities cliniques et therapeutiques a Conakry. San Francisco, California: Academia; 2016.
   Google Scholar
• Edo AE, Eregie A, Edo G, et al. Outcomes of medical management of thyrotoxicosis in Benin City, Nigeria. Annals of Biomed Sci. 2016 Apr 7;15(1):120–124.
   Google Scholar
• Ogun OA, Adeleye JO. Severe ophthalmological complications of thyroid disease are rare in Ibadan, Southwestern Nigeria: results of a pilot study. Ophthalmol Eye Dis. 2016 Jan 1;8:OED.S32169.
   PubMedGoogle Scholar
• Boiro D, Diédhiou D, Niang B, et al. Hyperthyroidism in children at the University Hospital in Dakar (Senegal). Pan Afr Med J. 2017;28:10.
   PubMed Web of Science ®Google Scholar
• Debebe K, Genetu G, Feleke Y, et al. Clinical presentation and pregnancy outcome of thyroid diseases in pregnant women at national endocrine referral clinic of tikur anbessa specialized hospital, Addis Ababa, Ethiopia from June 2010 to June 2015. Thyroid Disorder Ther. 2017;6(1):209.
   Google Scholar
• Anakwue R. Thyrotoxicosis associated enhanced systolic function: lessons on possible therapeutic use of thyroid hormone in selected cases of low thyroid hormone levels and poor systolic function. Annals of Medical and Health Sciences Research [Internet]. 2018 [cited 2022 Apr 1]; Available from: https://www.amhsr.org/abstract/thyrotoxicosis-associated-enhanced-systolic-function-lessons-on-possible-therapeutic-use-of-thyroid-hormone-in-selected–4799.html
   Google Scholar
• Ayandipo OO, Orunmuyi AT, Akande TO, et al. Presentation and management outcomes of hyperthyroidism in a sub -Saharan African teaching hospital. Annals Thyroid Res. 2018;4(1):130–135.
   Google Scholar
• Azagoh-Kouadio R, Asse KV, Enoh J, et al. International journal of pediatrics and neonatal health hyperthyroidism of the child in Abidjan (Côte d’Ivoire). Retrospective study of 27 cases. Int J Ped & Neo Health. 2018;2(3):45–49.
   Google Scholar
• Gebreyohannes EA, Ayele EM, Tesfaye SA, et al. Normalization of thyroid function tests among thyrotoxicosis patients attending a University Hospital in North-West Ethiopia. Thyroid Res. 2019 Mar 23;12(1):3.
   PubMedGoogle Scholar
• Mulatu HA. Pattern and presentation of thyro-cardiac disease among patients with hyperthyroidism attending a tertiary hospital in Ethiopia: a cross sectional study. Ethiop J Health Sci. 2019 Jan;29(1):887–894.
   PubMed Web of Science ®Google Scholar
• Ojo O, Ikem R, Kolawole B, et al. Prevalence and clinical relevance of thyroid autoantibodies in patients with goitre in Nigeria. J Endocrinol Metabolism Diabetes South Afr. 2019 Sep 2;24(3):92–97.
   Web of Science ®Google Scholar
• Okafor EN, Ugonabo MC, Chukwukelu EE, et al. Prevalence and pattern of thyroid disorders among patients attending university of Nigeria teaching hospital, Enugu, Southeastern Nigeria. Niger Med J. 2019 Mar 1;60(2):62.
   PubMedGoogle Scholar
• Demba D, Mané DI, Kiné GF, et al. Dysthyroidism in elderly subjects. Open J Inter Med. [2020 Mar 31];10(2):181–189.
   Google Scholar
• Ersumo T, Burka M, Tamrat G. Hyperthyroidism in a private medical services center, Addis Ababa: a 5-year experience. Ethiop Med J. 2020;58(1):3–11.
   Google Scholar
• Mariko M, Traore B, Kane B, et al. Dysthyroidism in children and adolescents at the Mali hospital. Mali Med. 2020;35(1):56–61.
   Google Scholar
• Mohammed AP. Clinical profile and complications related to thyroid disorders among patients attending endocrine clinic of tikur anbessa specialized hospital. Ethiopia: Addis Ababa University; 2020.
   Google Scholar
• Abera BT, Abera MA, Berhe G, et al. Thyrotoxicosis and dilated cardiomyopathy in developing countries. BMC Endocr Disord. [2021 Jun 28];21(1):132.
   PubMed Web of Science ®Google Scholar
• Mendes J. A descriptive analysis of children and adolescents with Graves disease attending the paediatric endocrinology services of the Red Cross war memorial children’s hospital and Groote Schuur hospital over 20 years. South Africa: University of Cape Town; 2021. Master of Philosophy
   Google Scholar
• Ruto DL. Characterization of thyroid disorders among patients attending surgical clinic at Nakuru Level 5 hospital -. Nakuru County Kenya. [Kenya]: Moi University; 2021.
   Google Scholar
• Sylla H, Camara SN, Barry MS, et al. Surgical hyperthyroidism: epidemiological aspect and management difficulties in the visceral surgery department of the Donka National Hospital. GSC Adv Res Rev. 2021;9(2):36–44.
   Google Scholar
• Ogbera AO, Kuku SF. Epidemiology of thyroid diseases in Africa. Indian J Endocrinol Metab. 2011 Jul;15(Suppl2):S82–8.
   PubMedGoogle Scholar
• Sarfo-Kantanka O, Sarfo FS, Ansah EO, et al. Graves disease in central Ghana: clinical characteristics and associated factors. Clin Med Insights Endocrinol Diabetes. 2018 Jan 1;11:1179551418759076.
   Web of Science ®Google Scholar
• Odeniyi IA, Olopade OB, Fasanmade OA. Thyroid disorders in Africa: where do we stand? Nig Q J Hosp Med Internet]. 2018 [cited 2022 Apr 8];28(4). Available from: https://www.ajol.info/index.php/nqjhm/article/view/207278
   Google Scholar
• Adedapo KS, Onimode YA, Ejeh JE, et al. Avoidable challenges of a nuclear medicine facility in a developing nation. Indian J Nucl Med. 2013;28(4):195–199.
   PubMedGoogle Scholar
• Businge CB, Longo-Mbenza B, Kengne AP. Iodine nutrition status in Africa: potentially high prevalence of iodine deficiency in pregnancy even in countries classified as iodine sufficient. Public Health Nutr. 2021;24(12):3581–3586.
   PubMed Web of Science ®Google Scholar
• Teti C, Panciroli M, Nazzari E, et al. Iodoprophylaxis and thyroid autoimmunity: an update. Immunol Res. [2021 Apr 1];69(2):129–138.
   PubMed Web of Science ®Google Scholar
• Kumwenda S, Niang EHA, Orondo PW, et al. Challenges facing young African scientists in their research careers: a qualitative exploratory study. Malawi Med J. 2017 Mar;29(1):1–4.
   PubMed Web of Science ®Google Scholar
• Pearce EN. Diagnosis and management of thyrotoxicosis. BMJ. 2006 Jun 10;332(7554):1369–1373.
   PubMedGoogle Scholar
• kumar AA, Mohan A, Kumar P, et al. Scintigraphic profile of thyrotoxicosis patients and correlation with biochemical and sonological findings. J Clin Diagn Res. 2017 May;11(5):OC01–3.
   Web of Science ®Google Scholar
• Baladi IH, Rai AA, Ahmed SM. ECG changes in patients with primary hyperthyroidism. Pan Afr Med J Internet]. 2018 Feb 8 [cited 2022 Apr 8];30(246). Available from . [];(). https://www.panafrican-med-journal.com/content/article/30/246/full
   PubMedGoogle Scholar
• Allahabadia A, Daykin J, Holder RL, et al. Age and gender predict the outcome of treatment for Graves’ hyperthyroidism*. J Clin Endocrinol Metab. 2000 Mar 1;85(3):1038–1042.
   PubMed Web of Science ®Google Scholar
• Vos XG, Smit N, Endert E, et al. Age and stress as determinants of the severity of hyperthyroidism caused by Graves’ disease in newly diagnosed patients. Eur J Endocrinol. 2009 Feb 1;160(2):193–199.
   PubMed Web of Science ®Google Scholar
• Tamatea JAU, Reid P, Conaglen JV, et al. Thyrotoxicosis in an indigenous New Zealand population – a prospective observational study. J Endocr Soc. 2020 Mar 1;4(3):bvaa002.
   PubMed Web of Science ®Google Scholar
• Desai MK, Brinton RD. Autoimmune disease in women: endocrine transition and risk across the lifespan. Front Endocrinol (Lausanne). 2019 [cited 2022 May 7];10. Internet: https://www.frontiersin.org/article/10.3389/fendo.2019.00265
   Web of Science ®Google Scholar
• Amino N, Tada H, Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid. 1999 Jul;9(7):705–713.
   PubMed Web of Science ®Google Scholar
• Singh N, Perfect JR. Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis. 2007 Nov 1;45(9):1192–1199.
   PubMed Web of Science ®Google Scholar
• Laurberg P, Bülow Pedersen I, Knudsen N, et al. Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid. 2001 May;11(5):457–469.
   PubMed Web of Science ®Google Scholar
• Li J, Bai L, Wei F, et al. Effect of addition of thyroxine in the treatment of Graves’ disease: a systematic review. Front Endocrinol (Lausanne). 2021; [cited 2022 May 7] 11 Internet https://www.frontiersin.org/article/10.3389/fendo.2020.560157
   Web of Science ®Google Scholar
• Gilbert J. Thyrotoxicosis – investigation and management. Clin Med. 2017 Jun 1;17(3):274–277.
   PubMed Web of Science ®Google Scholar
• Okosieme OE. Impact of iodination on thyroid pathology in Africa. J R Soc Med. 2006 Aug;99(8):396–401.
   PubMed Web of Science ®Google Scholar
• Saha S, Abu BAZ, Jamshidi-Naeini Y, et al. Is iodine deficiency still a problem in sub-Saharan Africa?: a review. Proc Nutr Soc. 2019 Nov;78(4):554–566.
   PubMed Web of Science ®Google Scholar
• Duan J, Kang J, Deng T, et al. Exposure to DBP and high iodine aggravates autoimmune thyroid disease through increasing the levels of IL-17 and thyroid-binding globulin in Wistar rats. Toxicol Sci. 2018 May 1;163(1):196–205.
   PubMed Web of Science ®Google Scholar
• Lucas A, Salinas I, Rius F, et al. Medical therapy of Graves’ disease: does thyroxine prevent recurrence of hyperthyroidism? J Clin Endocrinol Metab. [1997 Aug 1];82(8):2410–2413.
   PubMed Web of Science ®Google Scholar
• L LIU, LU H, Y LIU, et al. Predicting relapse of Graves’ disease following treatment with antithyroid drugs. Exp Ther Med. 2016 Apr;11(4):1453–1458.
   PubMed Web of Science ®Google Scholar
• Hussain YS, Hookham JC, Allahabadia A, et al. Epidemiology, management and outcomes of Graves’ disease—real life data. Endocrine. 2017 Jun 1;56(3):568–578.
   PubMed Web of Science ®Google Scholar
• Liu J, Fu J, Xu Y, et al. Antithyroid drug therapy for Graves’ disease and implications for recurrence. Int J Endocrinol. 2017;2017:3813540.
   PubMed Web of Science ®Google Scholar
• Park SM, Cho YY, Joung JY, et al. Excessive iodine intake does not increase the recurrence rate of Graves’ disease after withdrawal of the antithyroid Drug in an iodine-replete area. ETJ. 2015;4(1):36–42.
   Google Scholar
• Taylor PN, Albrecht D, Scholz A, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018 May;14(5):301–316.
   PubMed Web of Science ®Google Scholar
• Adambounou K, Ahonyi KA, Houndetoungan GD, et al. Knowledge and perception of nuclear medicine by radiologists in French-speaking sub-Saharan Africa. Asia Ocean J Nucl Med Biol. 2022;10(1):68–77.
   PubMedGoogle Scholar
• Onimode YA, Ankrah A, Adedapo KS. Outcome of Radioiodine Therapy in a West African population. World J Nucl Med. 2016;15(1):24–29.
   PubMedGoogle Scholar
• Kitahara CM, Berrington de Gonzalez A, Bouville A, et al. Association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism. JAMA Intern Med. [2019 Aug 1];179(8):1034–1042.
   PubMed Web of Science ®Google Scholar
• Bojic T, Paunovic I, Diklic A, et al. Total thyroidectomy as a method of choice in the treatment of Graves’ disease - analysis of 1432 patients. BMC Surg. [2015 Apr 9];15(1):39.
   PubMedGoogle Scholar
• Abate SM, Chekol YA, Basu B. Global prevalence and determinants of preoperative anxiety among surgical patients: a systematic review and meta-analysis. Int J Surg Open. 2020 Jan 1;25:6–16.
   Web of Science ®Google Scholar
• Pereira Pérez F, Calvo Espino P, Sánchez Arteaga A, et al. Thyroid surgery at a volunteer program in Sub-Saharan Africa. Cir Esp. [2016 Aug 1];94(7):404–409.
   PubMed Web of Science ®Google Scholar